Next 10 |
ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that it will voluntarily transfe...
Rexahn Pharmaceuticals (NYSEMKT: RNN ): Q1 GAAP EPS of -$0.62 beats by $0.39 . Cash, Cash Equivalents and Marketable Securities of $18.02M Press Release More news on: Rexahn Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced financial results for the first ...
Deals and Financings Hutchison China MediTech (Chi-Med) [AIM:HCM] (HCM) filed to IPO on the Hong Kong Exchange, following listings in London and on NASDAQ, where it has a market capitalization of over $4 billion (see story ). In September 2018, Chi-Med was approved to launch fruquintinib in...
April 17, 2019 Palm Beach, FL – April 17, 2019 – The American Association for Cancer Research (AARC) recently released an article that interviewed Nobel Laureate, Fellow of the AACR Academy, and immunotherapy pioneer James P. Allison, PhD and AACR President-elec...
Gainers : Rexahn Pharmaceuticals (NYSEMKT: RNN ) +28% . UP Fintech Holding (NASDAQ: TIGR ) +21% . Iconix Brand Group (NASDAQ: ICON ) +22% . ReWalk Robotics (NASDAQ: RWLK ) +16% . Future FinTech Group (NASDAQ: FTFT ) +13% . 360 Finance (NASDAQ: QFIN ) +13% . FTS International (NY...
Rexahn Pharmaceuticals (NYSEMKT: RNN ) +69% on RX-3117 collaboration in China. More news on: Rexahn Pharmaceuticals, Inc., ReWalk Robotics Ltd., Motif Bio plc, Stocks on the move, Read more ...
Rexahn Pharmaceuticals (NYSEMKT: RNN ) and BioSense Global LLC, a New Jersey and China-based biopharma company, have entered into a collaboration and license agreement to develop and commercialize RX-3117 for pancreatic cancer and other cancers in Greater China. More news on: Rexahn...
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New Jersey- and Suzhou, China-based biopharmaceutical company, today announced ...
Rexahn Pharmaceuticals (NYSEMKT: RNN ) announces that 1-for-12 reverse stock split of common stock became effective today. More news on: Rexahn Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Inc. Company Name:
RNN Stock Symbol:
NYSE Market:
Rexahn Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that it will voluntarily transfe...
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced financial results for the first ...
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New Jersey- and Suzhou, China-based biopharmaceutical company, today announced ...